In accordance with a previous study [41], our results showed that the IL-18 promoter -607 A/C polymorphism was almost equally distributed between ITP patients and the controls, which indicated that it may not be used as a stratification marker to predict the susceptibility to Chinese ITP. Here, IL18 is linked to autoimmune thrombocytopenic purpura.